MT-2 Pre-filled Pen

PRODUCT DESCRIPTION
Peptide Name: MT-2 (Melanotan II)
Chemical Name: Acetyl-L-norleucyl-L-alpha-aspartyl-L-histidyl-D-phenylalanyl-L-arginyl-L-tryptophyl-L-lysinamide (2->7)-lactam
CAS Number: 121062-08-6
 
DESCRIPTION
MT-2 is a synthetic analog of the naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH). It acts as a non-selective agonist of melanocortin receptors (MC1, MC3, MC4, and MC5). By mimicking the body's natural hormones, it triggers physiological responses related to pigmentation and metabolic regulation. Historically developed at the University of Arizona, researchers sought a more stable and potent alternative to natural MSH to potentially protect against UV-induced skin damage by inducing a protective tan without the need for high-level sun exposure.
Melanogenesis: Research indicates it stimulates the MC1 receptor to increase melanin production in the skin.
Sexual Health: Clinical trials have explored its role in treating erectile dysfunction and female sexual arousal disorder through MC4 receptor activation.
Metabolic Regulation: Studies in animal models suggest it may act on the central nervous system to suppress appetite and reduce body mass.
Social Behavior: Recent pilot studies in mice have investigated its potential impact on improving sociability deficits.
 
KIT INCLUDES
1x Pre-filled Pen
1x Travel Case
20x Alcohol swabs
20x Pen Tips (more pen tips can be bought separately)
 
REGULATORY NOTICES
SAHPRA DISCLAIMER This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA). It is not intended to diagnose, treat, cure, or prevent any disease.
RESEARCH USE ONLY
 
SCIENTIFIC STUDIES
Activation of the central melanocortin system chronically reduces body mass: https://pmc.ncbi.nlm.nih.gov/articles/PMC5572812/
Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation: https://pmc.ncbi.nlm.nih.gov/articles/PMC7013727/
Melanotan Tanning Injection: A Rare Cause of Priapism: https://pmc.ncbi.nlm.nih.gov/articles/PMC7930850/
Evaluation of melanotan-II in a pilot phase-I clinical study: https://pubmed.ncbi.nlm.nih.gov/8637402/